Randomized Controlled Trial of Treating Migraine With Acupuncture
NCT ID: NCT00599586
Last Updated: 2010-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
480 participants
INTERVENTIONAL
2007-11-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture for Migraine Prophylaxis
NCT01687660
Acupuncture for Patients With Chronic Tension-type Headache
NCT03133884
Acupuncture for Migraine: a Functional Magnetic Resonance Imaging (fMRI) Study
NCT01152632
Acupuncture for the Treatment of Chronic Daily Headaches
NCT00086021
The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine
NCT07023926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1
specific acupoints of Shaoyang meridians
acupuncture
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
Group 2
Non-specific acupoints of Shaoyang meridians
acupuncture
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
group 3
Acupoints of other meridians
acupuncture
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
group 4
Non-acupoints
acupuncture
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture
Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Consistent with the diagnostic criteria of Premonitory Migraine and Non- Premonitory Migraine.
3. Attacks of migraine are equal to or more than 2 times in the last three months.
4. With more than one year history of migraine
5. Informed consent is signed by a subject or his lineal relation.
Exclusion Criteria
2. Psychotic，patients with allergic constitution or easily getting infected or bleeding.
3. Patients have used drugs for preventing migraine in the last four weeks.
4. Pregnant women or women in lactation.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chengdu University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Acupuncture & Tuina college of chengdu univeristy of TCM
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fan-rong Liang, master
Role: STUDY_CHAIR
Chengdu University of TCM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chengdu University of TCM
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melchart D. Acupuncture for patients with migraine: a randomized controlled trial. JAMA. 2005 May 4;293(17):2118-25. doi: 10.1001/jama.293.17.2118.
Zheng H, Huang W, Li J, Zheng Q, Li Y, Chang X, Sun G, Liang F. Association of pre- and post-treatment expectations with improvements after acupuncture in patients with migraine. Acupunct Med. 2015 Apr;33(2):121-8. doi: 10.1136/acupmed-2014-010679. Epub 2014 Dec 30.
Deng ZQ, Zheng H, Zhao L, Zhou SY, Li Y, Liang FR. Health economic evaluation of acupuncture along meridians for treating migraine in China: results from a randomized controlled trial. BMC Complement Altern Med. 2012 Jun 14;12:75. doi: 10.1186/1472-6882-12-75.
Li Y, Zheng H, Witt CM, Roll S, Yu SG, Yan J, Sun GJ, Zhao L, Huang WJ, Chang XR, Zhang HX, Wang DJ, Lan L, Zou R, Liang FR. Acupuncture for migraine prophylaxis: a randomized controlled trial. CMAJ. 2012 Mar 6;184(4):401-10. doi: 10.1503/cmaj.110551. Epub 2012 Jan 9.
Zhao L, Zhang FW, Li Y, Wu X, Zheng H, Cheng LH, Liang FR. Adverse events associated with acupuncture: three multicentre randomized controlled trials of 1968 cases in China. Trials. 2011 Mar 24;12:87. doi: 10.1186/1745-6215-12-87.
Li Y, Liang F, Yu S, Liu X, Tang Y, Yang X, Tian X, Yan J, Sun G, Chang X, Zheng H, Zhang H, Ma T. Randomized controlled trial to treat migraine with acupuncture: design and protocol. Trials. 2008 Oct 20;9:57. doi: 10.1186/1745-6215-9-57.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006CB5045011
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2006CB5045011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.